VIDEO: Finerenone reduces CKD progression in diabetic kidney disease
Click Here to Manage Email Alerts
Linda F. Fried, MD, MPH, FASN, co-chair of ASN Kidney Week Education Committee, discussed data presented at ASN Kidney Week showing finerenone effective in slowing the progression of chronic kidney disease in patients with diabetes.
Finerenone also reduced the risk for cardiac events, according to Fried. Although the researchers did not observe much hyperkalemia in this study, the average potassium levels were higher, prompting Fried to caution that there may be more hyperkalemia in real world populations.
“This whole meeting ... after many negative studies over the last few years, we’re beginning to have compounds that decrease progression of kidney disease or improve outcomes and it’s hopefully an exciting time in nephrology,” Fried, of University of Pittsburgh, VA Pittsburgh Healthcare System, said.
Collapse
Agarwal R. #FR-OR51. Presented at: ASN Kidney Week. Oct. 22-25, 2020 (virtual meeting).
Read more about
Click Here to Manage Email Alerts